^ Jump up to: a b Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS (January 2009). "5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats". British Journal of Pharmacology. 156 (1): 181–8. doi:10.1111/j.1476-5381.2008.00046.x. PMC 2697769. PMID 19133999.
SteepFuze is proud to offer gourmet CBD Infused Coffee, but our story does not end here! For our friends who aren’t coffee drinkers, we’re happy to provide infused teas as another means of consuming CBD. Our steam extracted capsules provide a very clean CBD compared to most on the market, and supply that extra potency that some people desire. Kind people like you continue to request new products and provide invaluable feedback, so we are always hard at “work” in the lab improving formulations and developing the next innovative product… Thank you for joining us on our hemp and coffee journey. Cheers!
Strain-specific topicals attempt to harness certain terpenes and cannabinoids in a chemical profile similar to that of Blackberry Kush, Permafrost, Blueberry, or whatever other strains the processor wishes to imitate. Along with THC, CBD, THCA, and other cannabinoids, topical producers may also select ingredients and essential oils for additional relief, like cayenne, wintergreen, and clove.
…..i have an aggressive form of heart disease (atherosclerosis) and my on-line research into medical marijuana has uncovered that there are 2 main forms of canabidiol, CBD 1 and CBD 2. Current research is indicating that CBD 1 promotes the growth of arterial plaque while CBD 2 inhibits this growth. Thus, I would like to use a strain that is high in THC and high in CBD 2 with no CBD 1. Is there anything out there with this combination (THC/CBD2) ?? Thanks !!
In any case, California’s decision to ban CBD oil from hemp seems like it may be informed more by legalistic hair-splitting. And to illustrate how finely that hair is split, recall that CBD is a controlled substance under federal law, regardless of what it is derived from. Yet federal policy is also contradictory. The FDA’s recent approval of the CBD medicine Epidiolex comes despite the fact that the DEA considers CBD a Schedule I substance, with no medical applications. A DEA rescheduling or de-scheduling of CBD would go a long way toward resolving these questions — and is coming in the next three months.
INGREDIENTS: ALCOHOL DENAT., HAMAMELIS VIRGINIANA (WITCH HAZEL) WATER, WATER (AQUA), PROPYLENE GLYCOL, ALCOHOL, LIDOCAINE, POLYSORBATE 20, GLYCERIN, CANNABINOID EXTRACT, ARNICA MONTANA FLOWER EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, EUCALYPTUS GLOBULUS LEAF OIL, MENTHA PIPERITA (PEPPERMINT) OIL, CAMPHOR, MENTHOL, TOCOPHERYL ACETATE, ALLANTOIN, SODIUM BENZOATE, POTASSIUM SORBATE.
What makes CBD so appealing is that it’s non-intoxicating, so it won’t get you high, though it “is technically psychoactive, because it can influence things like anxiety,” Jikomes said. Although much of the marketing blitz around CBD centers on the fact that you can take it without getting stoned, there isn’t much research looking at the effects of CBD when used in isolation, with a couple of exceptions. One is the use of CBD to treat seizures: CBD is the active ingredient in the only cannabis product that the Food and Drug Administration has signed off on — a drug called Epidiolex, which is approved for treating two rare forms of epilepsy. Animal models and a few human studies suggest that CBD can help with anxiety, but those are the only conditions with much research on CBD in isolation.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.